Characterization and Outcomes of SARS-CoV-2 Infection in Overweight and Obese Patients: A Dynamic Comparison of COVID-19 Pandemic Waves.

COVID-19 SARS-CoV-2 infection disease severity obesity overweight

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
21 May 2022
Historique:
received: 20 04 2022
revised: 17 05 2022
accepted: 20 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

There are few data on the dynamics of SARS-CoV-2 viral manifestations in obese and overweight persons during each of the five waves that occurred in Romania during the last two years. As such, the purpose of this research was to characterize the variance in case severity, symptomatology, ICU hospitalizations, and mortality among overweight and obese individuals infected with the SARS-CoV-2 virus. We included 250 overweight and obese patients admitted to hospital with COVID-19, where 50 patients were selected from each of the five pandemic waves that existed in Romania until March 2022. A total of 113 patients with normal body mass index were included in the study. They were matched with overweight and obese patients by age, gender, and cardiovascular comorbidities to avoid the effect of confounding factors. Between the five waves of the COVID-19 pandemic in Romania, the present investigation found substantial changes in overweight and obese patient features. Obesity increases the risk of hospitalization, severe complications, and mortality from COVID-19. However, this unique demographic is disproportionately affected by obesity-related comorbidities, which contribute to these adverse outcomes. We advocate for the development of new guiding principles for the formulation of healthcare strategies aimed at high-prevalence special populations such as overweight and obese individuals, while also promoting pandemic containment and avoiding the recurrence of pandemic waves with the same guidelines that proved detrimental in terms of economic and human life loss.

Identifiants

pubmed: 35629042
pii: jcm11102916
doi: 10.3390/jcm11102916
pmc: PMC9143838
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Diagnostics (Basel). 2022 Mar 27;12(4):
pubmed: 35453871
Lancet Infect Dis. 2022 Jul;22(7):1002-1010
pubmed: 35405090
J Clin Med. 2021 Jun 16;10(12):
pubmed: 34208640
Int J Infect Dis. 2021 Mar;104:742-745
pubmed: 33556610
Medicina (Kaunas). 2021 Aug 01;57(8):
pubmed: 34441002
Pathogens. 2021 Aug 30;10(9):
pubmed: 34578140
J Clin Med. 2022 Mar 02;11(5):
pubmed: 35268473
J Pers Med. 2022 Apr 11;12(4):
pubmed: 35455729
Eur J Heart Fail. 2020 Jun;22(6):967-974
pubmed: 32485082
Anaesthesia. 2020 Jun;75(6):724-732
pubmed: 32221973
Int J Environ Res Public Health. 2022 Jan 29;19(3):
pubmed: 35162597
Infect Dis Rep. 2021 Apr 09;13(2):340-347
pubmed: 33918578
Expert Rev Respir Med. 2018 Sep;12(9):755-767
pubmed: 30056777
CMAJ. 2020 Jun 29;192(26):E694-E701
pubmed: 32461326
Obes Med. 2020 Sep;19:100283
pubmed: 32835126
Front Aging Neurosci. 2021 Jan 12;12:614650
pubmed: 33510633
Lancet Microbe. 2021 Dec;2(12):e666-e675
pubmed: 34632431
Sci Rep. 2021 Mar 23;11(1):6638
pubmed: 33758267
Viruses. 2022 Feb 02;14(2):
pubmed: 35215900
Antibiotics (Basel). 2022 Mar 24;11(4):
pubmed: 35453189
J Evid Based Med. 2020 Feb;13(1):3-7
pubmed: 32048815
Life (Basel). 2022 Feb 03;12(2):
pubmed: 35207518
Int J Surg Oncol (N Y). 2017 Aug;2(7):e17
pubmed: 29177227
J Clin Med. 2022 Apr 18;11(8):
pubmed: 35456343
Glob Pediatr Health. 2019 Dec 1;6:2333794X19891305
pubmed: 31832491
BMC Public Health. 2021 Aug 4;21(1):1505
pubmed: 34348687
Postgrad Med J. 2021 May;97(1147):273-274
pubmed: 33563705
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Hum Vaccin Immunother. 2014;10(2):428-40
pubmed: 24165394
Int J Infect Dis. 2021 Apr;105:374-376
pubmed: 33684560
SN Compr Clin Med. 2020;2(8):1069-1076
pubmed: 32838147
Medicina (Kaunas). 2021 Jun 10;57(6):
pubmed: 34200570
Healthcare (Basel). 2022 Feb 12;10(2):
pubmed: 35206976
Nature. 2021 Aug;596(7871):276-280
pubmed: 34237773
R Soc Open Sci. 2020 Jul 22;7(7):200780
pubmed: 32874663
Int J Epidemiol. 2020 Jun 1;49(3):810-823
pubmed: 32016289
BMJ Glob Health. 2022 Feb;7(2):
pubmed: 35193893
Obes Sci Pract. 2020 Dec 24;7(2):137-147
pubmed: 33841883
Int J Environ Res Public Health. 2020 Jun 02;17(11):
pubmed: 32498226
Diagnostics (Basel). 2022 Mar 29;12(4):
pubmed: 35453894
Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-798
pubmed: 34619105
Infect Dis Poverty. 2020 Mar 17;9(1):29
pubmed: 32183901
Viruses. 2021 Jun 22;13(7):
pubmed: 34206453
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Int J Antimicrob Agents. 2020 Jun;55(6):105948
pubmed: 32201353
Int J Environ Res Public Health. 2021 Jun 10;18(12):
pubmed: 34200934
Int J Environ Res Public Health. 2022 Jan 24;19(3):
pubmed: 35162304
Lancet. 2021 Mar 13;397(10278):952-954
pubmed: 33581803

Auteurs

Roxana Manuela Fericean (RM)

Department XIII, Discipline of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Doctoral School, ''Victor Babes'' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Cosmin Citu (C)

Department of Obstetrics and Gynecology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.

Diana Manolescu (D)

Department of Radiology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Ovidiu Rosca (O)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Felix Bratosin (F)

Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Emanuela Tudorache (E)

Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Cristian Oancea (C)

Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Classifications MeSH